跳至主要内容
临床试验/ISRCTN13659155
ISRCTN13659155已完成未知

Fluid hydration to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis

Radboud University Medical Center0 个研究点目标入组 826 人开始时间: 2015年5月18日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
826

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Requiring ERCP
  • 2. Between 18 and 85 years of age
  • 3. Signed informed consent

排除标准

  • 1. Allergy to NSAIDs or other contraindications
  • 2. Ongoing acute pancreatitis
  • 3. Ongoing hypotension, including those with sepsis
  • 4. Cardiac insufficiency (CI, >NYHA Class I heart failure)
  • 5. Renal insufficiency (RI, creatinin clearance <40ml/min)
  • 6. Active ulcer disease
  • 7. Severe liver dysfunction: liver cirrhosis and ascites
  • 8. Respiratory insufficiency (pO2<60mmHg or 90% despite FiO2 of 30% or requiring mechanical ventilation)
  • 9. Pregnancy
  • 10. Hyponatremia (Na+ levels < 130mmol/l)
  • 11. Hypernatremia (Na+ levels > 150mmol/l)
  • 12. Oedema
  • 13. Low risk of PEP: chronic calcific pancreatitis (PD intervention is allowed) or pancreatic head mass or routine biliary stent exchange or re-ERCP with a history of endoscopicsphincterotomy with a CBD intervention (PD intervention is allowed)

研究者

相似试验